Filippo Carlucci

Siena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis.

A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis.

Journal: Communications medicine

Published: September 02, 2024

In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking.

In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking.

Journal: Nature

Published: February 08, 2024

A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.

A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.

Journal: Nature communications

Published: October 13, 2023

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.

Journal: Nature medicine

Published: August 31, 2022

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Journal: Journal of endocrinological investigation

Published: September 28, 2019

Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.

Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.

Journal: Scientific reports

Published: February 25, 2016

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Journal: Blood

Published: January 01, 2016

Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin.

Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin.

Journal: Cancer letters

Published: November 12, 2014

Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.

Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.

Journal: Blood

Published: December 21, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026